Outcomes after ecallantide treatment of laryngeal hereditary angioedema attacks

Annals of Allergy, Asthma and Immunology

Volumn 110, Issue 3, 2013, Pages

  Sheffer, Albert L ^a   Macginnitie, Andrew J ^b   Campion, Marilyn ^c   Stolz, Leslie E ^c   Pullman, William E ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c Dyax Corp   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; CORTICOSTEROID; DANAZOL; DIPHENHYDRAMINE; ECALLANTIDE; FRESH FROZEN PLASMA; METHYLPREDNISOLONE; OXYGEN; PREDNISONE; SALBUTAMOL;

ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; DRUG EFFICACY; DRUG RECHALLENGE; DRUG SAFETY; ERYTHEMA; FLUSHING; HOSPITALIZATION; HUMAN; HYPOTENSION; INTUBATION; LARYNX EDEMA; MEAN SYMPTOM COMPLEX SEVERITY SCORE; MULTICENTER STUDY (TOPIC); PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); POST HOC ANALYSIS; PRIORITY JOURNAL; PRURITUS; SCORING SYSTEM; SIDE EFFECT; THORAX PAIN; TREATMENT OUTCOME SCORE;

EID: 84875214648     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2012.12.007     Document Type: Article

References (32)

1. B.L. Zuraw Clinical practice: hereditary angioedema N Engl J Med 359 2008 1027 1036
2. W.R. Lumry, A.J. Castaldo, M.K. Vernon, M.B. Blaustein, D.A. Wilson, and P.T. Horn The humanistic burden of hereditary angioedema: impact on health-related quality of life, productivity, and depression Allergy Asthma Proc 31 2010 407 414
3. D.A. Wilson, K. Bork, E.P. Shea, A.M. Rentz, M.B. Blaustein, and W.E. Pullman Economic costs associated with acute attacks and long-term management of hereditary angioedema Ann Allergy Asthma Immunol 104 2010 314 320
4. A. Agostoni, E. Aygoren-Pursun, and K.E. Binkley Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond J Allergy Clin Immunol 114 3 suppl 2004 S51 S131
5. A.E. Davis III, A.S. Whitehead, and R.A. Harrison Human inhibitor of the first component of complement, C1: characterization of cDNA clones and localization of the gene to chromosome 11 Proc Natl Acad Sci U S A 83 1986 3161 3165
6. A.P. Kaplan, and K. Joseph The bradykinin-forming cascade and its role in hereditary angioedema Ann Allergy Asthma Immunol 104 2010 193 204
7. K. Bork, J. Hardt, K.-H. Schicketanz, and N. Ressel Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency Arch Intern Med 163 2003 1229 1235
8. K. Bork, K. Siedlecki, S. Bosch, R.E. Schopf, and W. Kreuz Asphyxiation by laryngeal edema in patients with hereditary angioedema Mayo Clin Proc 75 2000 349 354
9. K. Bork, G. Meng, P. Staubach, and J. Hardt Hereditary angioedema: new findings concerning symptoms, affected organs, and course Am J Med 119 2006 267 274
10. K. Bork, J. Hardt, and G. Witzke Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency J Allergy Clin Immunol 130 2012 692 697
11. H. Farkas Management of upper airway edema caused by hereditary angioedema Allergy Asthma Clin Immunol 6 2010 19
12. E. Papadopoulou-Alataki Upper airway considerations in hereditary angioedema Curr Opin Allergy Clin Immunol 10 2010 20 25
13. K.P. Garnock-Jones Ecallantide: in acute hereditary angioedema Drugs 70 2010 1423 1431
14. L.E. Stolz, and A.L. Sheffer Prospective, double-blind, placebo-controlled trials of ecallantide for acute attacks of hereditary angioedema Expert Rev Clin Immunol 8 2012 25 32
15. J.A. Bernstein, and M. Qazi Ecallantide: its pharmacology, pharmacokinetics, clinical efficacy and tolerability Expert Rev Clin Immunol 6 2010 29 39
16. M. Cicardi, R.J. Levy, and D.L. McNeil Ecallantide for the treatment of acute attacks in hereditary angioedema N Engl J Med 363 2010 523 531
17. R.J. Levy, W.R. Lumry, and D.L. McNeil EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema Ann Allergy Asthma Immunol 104 2010 523 529
18. M. Riedl, M. Campion, P.T. Horn, and W.E. Pullman Response time for ecallantide treatment of acute hereditary angioedema attacks Ann Allergy Asthma Immunol 105 2010 430 436
19. A.L. Sheffer, M. Campion, R.J. Levy, H.H. Li, P.T. Horn, and W.E. Pullman Ecallantide (DX-88) for acute hereditary angioedema attacks: integrated analysis of 2 double-blind, phase 3 studies J Allergy Clin Immunol 128 2011 153 159.e4
20. A.J. MacGinnitie, M. Campion, L.E. Stolz, and W.E. Pullman Ecallantide for treatment of acute hereditary angioedema attacks: analysis of efficacy by patient characteristics Allergy Asthma Proc 33 2012 178 185
21. M.K. Vernon, A.M. Rentz, K.W. Wyrwich, M.V. White, and A. Grienenberger Psychometric validation of two patient-reported outcome measures to assess symptom severity and changes in symptoms in hereditary angioedema Qual Life Res 18 2009 929 939
22. M. Cicardi, L. Bergamaschini, B. Marasini, G. Boccassini, A. Tucci, and A. Agostoni Hereditary angioedema: an appraisal of 104 cases Am J Med Sci 284 1982 2 9
23. N.S. Landerman Hereditary angioneurotic edema, I: case reports and review of the literature J Allergy 33 1962 316 329
24. A. Agostoni, and M. Cicardi Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients Medicine (Baltimore) 71 1992 206 215
25. E. Banta, P. Horn, and T.J. Craig Response to ecallantide treatment of acute attacks of hereditary angioedema based on time to intervention: results from the EDEMA clinical trials Allergy Asthma Proc 32 2011 319 324
26. K. Bork, G. Meng, P. Staubach, and J. Hardt Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema Transfusion 45 2005 1774 1784
27. M. Cicardi, A. Banerji, and F. Bracho Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema N Engl J Med 363 2010 532 541
28. T.J. Craig, R.J. Levy, and R.L. Wasserman Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks J Allergy Clin Immunol 124 2009 801 808
29. W.R. Lumry, H.H. Li, and R.J. Levy Randomized placebo-controlled trial of the bradykinin B(2) receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial Ann Allergy Asthma Immunol 107 2011 529 537.e2
30. B. Zuraw, M. Cicardi, and R.J. Levy Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema J Allergy Clin Immunol 126 2010 821 827.e14
31. T.J. Craig, A.K. Bewtra, and S.L. Bahna C1 esterase inhibitor concentrate in 1085 hereditary angioedema attacks: final results of the I.M.P.A.C.T.2 study Allergy 66 2011 1604 1611
32. T.J. Craig, R.L. Wasserman, and R.J. Levy Prospective study of rapid relief provided by C1 esterase inhibitor in emergency treatment of acute laryngeal attacks in hereditary angioedema J Clin Immunol 30 2010 823 829